These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 30579343)

  • 21. Genetic and molecular determinants of prostate cancer among Iranian patients: An update.
    Ghayour-Mobarhan M; Ferns GA; Moghbeli M
    Crit Rev Clin Lab Sci; 2020 Jan; 57(1):37-53. PubMed ID: 31895010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Familial colorectal cancer screening: When and what to do?
    Del Vecchio Blanco G; Paoluzi OA; Sileri P; Rossi P; Sica G; Pallone F
    World J Gastroenterol; 2015 Jul; 21(26):7944-53. PubMed ID: 26185367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical applications of next-generation sequencing in colorectal cancers.
    Kim TM; Lee SH; Chung YJ
    World J Gastroenterol; 2013 Oct; 19(40):6784-93. PubMed ID: 24187453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High frequency of KRAS mutation in early onset colorectal adenocarcinoma: implications for pathogenesis.
    Watson R; Liu TC; Ruzinova MB
    Hum Pathol; 2016 Oct; 56():163-70. PubMed ID: 27346571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colorectal Cancer Biomarkers: Where Are We Now?
    Gonzalez-Pons M; Cruz-Correa M
    Biomed Res Int; 2015; 2015():149014. PubMed ID: 26106599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colorectal cancer molecular biology moves into clinical practice.
    Pritchard CC; Grady WM
    Gut; 2011 Jan; 60(1):116-29. PubMed ID: 20921207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic biomarkers in colorectal cancer: premises and prospects.
    Zamani M; Hosseini SV; Mokarram P
    Biomarkers; 2018 Mar; 23(2):105-114. PubMed ID: 27788596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of cell-free DNA in predicting colorectal cancer prognosis.
    Cao B; Zhou X; Yang W; Ma J; Zhou W; Fan D; Hong L
    Expert Rev Gastroenterol Hepatol; 2018 Jan; 12(1):39-48. PubMed ID: 28838275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serrated colorectal cancer: Molecular classification, prognosis, and response to chemotherapy.
    Murcia O; Juárez M; Hernández-Illán E; Egoavil C; Giner-Calabuig M; Rodríguez-Soler M; Jover R
    World J Gastroenterol; 2016 Apr; 22(13):3516-30. PubMed ID: 27053844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic and molecular biology of bladder cancer among Iranian patients.
    Mojarrad M; Moghbeli M
    Mol Genet Genomic Med; 2020 Jun; 8(6):e1233. PubMed ID: 32253828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-coding landscapes of colorectal cancer.
    Ragusa M; Barbagallo C; Statello L; Condorelli AG; Battaglia R; Tamburello L; Barbagallo D; Di Pietro C; Purrello M
    World J Gastroenterol; 2015 Nov; 21(41):11709-39. PubMed ID: 26556998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival marker genes of colorectal cancer derived from consistent transcriptomic profiling.
    Martinez-Romero J; Bueno-Fortes S; Martín-Merino M; Ramirez de Molina A; De Las Rivas J
    BMC Genomics; 2018 Dec; 19(Suppl 8):857. PubMed ID: 30537927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colorectal cancer tumour markers and biomarkers: Recent therapeutic advances.
    Lech G; Słotwiński R; Słodkowski M; Krasnodębski IW
    World J Gastroenterol; 2016 Feb; 22(5):1745-55. PubMed ID: 26855534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Copy number variations are progressively associated with the pathogenesis of colorectal cancer in ulcerative colitis.
    Shivakumar BM; Rotti H; Vasudevan TG; Balakrishnan A; Chakrabarty S; Bhat G; Rao L; Pai CG; Satyamoorthy K
    World J Gastroenterol; 2015 Jan; 21(2):616-22. PubMed ID: 25605985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current trends in clinical genetics of colorectal cancer.
    Markovic S; Dimitrijevic I; Zogovic B; Markovic V; Barisic G; Krivokapic Z
    J BUON; 2016; 21(5):1042-1049. PubMed ID: 27837603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic and epitranscriptomic changes in colorectal cancer: Diagnostic, prognostic, and treatment implications.
    Porcellini E; Laprovitera N; Riefolo M; Ravaioli M; Garajova I; Ferracin M
    Cancer Lett; 2018 Apr; 419():84-95. PubMed ID: 29360561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA in colorectal cancer: new perspectives for diagnosis, prognosis and treatment.
    Bonfrate L; Altomare DF; Di Lena M; Travaglio E; Rotelli MT; De Luca A; Portincasa P
    J Gastrointestin Liver Dis; 2013 Sep; 22(3):311-20. PubMed ID: 24078989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer.
    Okugawa Y; Toiyama Y; Toden S; Mitoma H; Nagasaka T; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A
    Gut; 2017 Jan; 66(1):107-117. PubMed ID: 26475630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MOLECULAR FEATURES AND MOUSE MODELS OF COLORECTAL CANCER.
    Fearon ER
    Trans Am Clin Climatol Assoc; 2018; 129():56-62. PubMed ID: 30166699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colorectal Cancer: From the Genetic Model to Posttranscriptional Regulation by Noncoding RNAs.
    Lizarbe MA; Calle-Espinosa J; Fernández-Lizarbe E; Fernández-Lizarbe S; Robles MÁ; Olmo N; Turnay J
    Biomed Res Int; 2017; 2017():7354260. PubMed ID: 28573140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.